National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

iodine I 125 anti-EGFR-425 monoclonal antibody
A radioimmunoconjugate consisting of a murine IgG2a monoclonal antibody directed against the human epidermal growth factor receptor (EGFR) labeled with iodine I 125 with potential antineoplastic activity. Iodine I 125 anti-EGFR-425 monoclonal antibody binds specifically to the epidermal growth factor receptor (EGFR). Upon binding to EGFR-expressing tumor cells, this agent is internalized, selectively delivering a potentially cytotoxic dose of gamma radiation. EGFR is a receptor tyrosine kinase that may be overexpressed on the cell surfaces of various solid tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:iodine 125-labeled anti-EGFR-425 monoclonal antibody
iodine 125-labeled anti-epidermal growth factor receptor-425 monoclonal antibody

Previous:iodine I 124, iodine I 124 chimeric monoclonal antibody G250, iodine I 124 iodo-azomycin galactopyranoside, iodine I 124 iododeoxyuridine, iodine I 125
Next:iodine I 131, iodine I 131 chimeric monoclonal antibody G-250, iodine I 131 ethiodized oil, Iodine I 131 Lipiodol, iodine I 131 monoclonal antibody 3F8